Effect of the ACE inhibitor lisinopril on mortality in diabetic patients with acute myocardial infarction: data from the GISSI-3 study

Circulation
G ZuanettiG Tognoni

Abstract

Mortality of diabetic patients with acute myocardial infarction (MI) remains high despite recent improvement in their management. There is a need to evaluate efficacy and safety of novel treatments of MI in this high-risk population. We evaluated whether treatment with an ACE inhibitor begun within 24 hours from the onset of symptoms is able to decrease mortality and morbidity of diabetic patients with acute MI. A retrospective analysis of the data of the GISSI-3 study in patients with and without a history of diabetes was performed. Patients with suspected acute MI were randomized to treatment with lisinopril (2.5 to 5 up to 10 mg/d) with or without nitroglycerin (5 to 20 microg I.V. then 10 mg/d) begun within 24 hours and continued for 6 weeks. The main end point was mortality at 6 weeks, and the secondary end point was a combined evaluation of mortality and severe left ventricular dysfunction. Information on diabetic status was available for 18,131 patients (approximately 94% of the total population enrolled), of whom 2790 patients had a history of diabetes. Treatment with lisinopril was associated with a decreased 6-week mortality in diabetic patients (8.7% versus 12.4%; OR, 0.68; 95% CI, 0.53 to 0.86; 37+/-12 lives saved p...Continue Reading

References

Oct 8, 1992·The American Journal of Cardiology·UNKNOWN GISSI-3-Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico
Sep 1, 1992·Journal of the American College of Cardiology·R M Jacoby, R W Nesto
Mar 1, 1985·Progress in Cardiovascular Diseases·S YusufP Sleight
Oct 1, 1984·The American Journal of Cardiology·J W SmithR Serokman
Dec 1, 1993·Journal of the American College of Cardiology·G ZuanettiM G Franzosi
Sep 1, 1996·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·G NavisP E de Jong
Jan 1, 1996·Wiener medizinische Wochenschrift·W H Hörl
Mar 1, 1997·Journal of Diabetes and Its Complications·G Zuanetti, R Latini

❮ Previous
Next ❯

Citations

Aug 1, 1994·Cardiovascular Drugs and Therapy·B I Jugdutt
Feb 5, 2009·Current Diabetes Reports·Rodrigo M Lago, Richard W Nesto
Feb 9, 2002·European Journal of Pharmacology·J R OrtleppH G Joost
May 15, 2002·Fertility and Sterility·Philip M Sarrel
Aug 10, 2000·Journal of the American College of Cardiology·T HammoudM G Bourassa
Jan 12, 2001·Journal of the American College of Cardiology·J H O'KeefeC J Lavie
Sep 3, 2002·Journal of the American College of Cardiology·Steven P Marso
Nov 13, 2002·Journal of the American College of Cardiology·Steven P SedlisUNKNOWN Investigators of the Dept. of Veterans Affairs Cooperative Study #385, the Angina With Extremely Serious Operative Mortality
Jan 10, 2001·Endocrinology and Metabolism Clinics of North America·B W Paty
Feb 12, 2002·European Journal of Internal Medicine·A M. WagnerA Perez-Perez
Jul 26, 2002·Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology·Daniela GrimmEckhard P Kromer
Jun 10, 2000·Journal of Advanced Nursing·M StewartL Makrides
Apr 30, 2013·European Heart Journal·Joshua A BeckmanMark A Creager
Sep 15, 1998·Journal of Cardiovascular Pharmacology·C Borghi, E Ambrosioni
Dec 7, 2000·Australian and New Zealand Journal of Medicine·H M FarouqueI T Meredith
Feb 22, 2013·The Journal of Clinical Investigation·Min LuoMark E Anderson
Aug 27, 2003·Circulation Journal : Official Journal of the Japanese Circulation Society·Takayuki FujinoNaoyuki Hasebe
Feb 24, 2001·Hypertension Research : Official Journal of the Japanese Society of Hypertension·T SugawaraA Kitabatake
Feb 24, 2006·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Anna C Calkin, Terri J Allen
May 1, 2008·Future Cardiology·Ahmed Zaiem, Faiez Zannad
Apr 3, 2001·Coronary Artery Disease·J D Rutherford
Nov 4, 2006·Expert Review of Cardiovascular Therapy·Hendrik Buikema
Aug 22, 2006·Expert Review of Cardiovascular Therapy·L Romayne KurukulasuriyaJames Sowers
Mar 16, 2001·Expert Opinion on Pharmacotherapy·A Prasad, G Reeder
Nov 20, 2002·Expert Opinion on Investigational Drugs·Sunil Nadar, Gregory Y H Lip
Aug 28, 2004·Expert Opinion on Pharmacotherapy·Claudio BorghiEttore Ambrosioni
Apr 7, 2005·Current Medical Research and Opinion·M Hanefeld
May 12, 2001·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·I MahéJ F Bergmann
Dec 25, 2003·The Journal of Physiology·Yakhin ShimoniDavid L Severson
Jun 5, 2003·The Journal of Physiology·Yakhin Shimoni, Xiu-Fang Liu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Cardiology Journals

Discover the latest cardiology research in this collection of the top cardiology journals.